APA (7th ed.) Citation

SJ, M., ML, H., SL, W., A, D., LJ, I., D, K., . . . D, L. (2022). Bezlotoxumab prevents extraintestinal organ damage induced by Clostridioides difficile infection. Gut microbes, 14(1), 2117504. https://doi.org/10.1080/19490976.2022.2117504

Chicago Style (17th ed.) Citation

SJ, Mileto, et al. "Bezlotoxumab Prevents Extraintestinal Organ Damage Induced by Clostridioides Difficile Infection." Gut Microbes 14, no. 1 (2022): 2117504. https://doi.org/10.1080/19490976.2022.2117504.

MLA (9th ed.) Citation

SJ, Mileto, et al. "Bezlotoxumab Prevents Extraintestinal Organ Damage Induced by Clostridioides Difficile Infection." Gut Microbes, vol. 14, no. 1, 2022, p. 2117504, https://doi.org/10.1080/19490976.2022.2117504.